In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.

Weber LA, Funtan A, Paschke R, Delarocque J, Kalbitz J, Meißner J, Feige K, Kietzmann M, Cavalleri JV

Open source

DOI
10.1371/journal.pone.0241448
Published
2020
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0241448,
  title = {In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.},
  author = {Weber LA and Funtan A and Paschke R and Delarocque J and Kalbitz J and Meißner J and Feige K and Kietzmann M and Cavalleri JV},
  year = {2020},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0241448},
  url = {https://doi.org/10.1371/journal.pone.0241448}
}

RIS

TY  - JOUR
TI  - In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.
AU  - Weber LA
AU  - Funtan A
AU  - Paschke R
AU  - Delarocque J
AU  - Kalbitz J
AU  - Meißner J
AU  - Feige K
AU  - Kietzmann M
AU  - Cavalleri JV
PY  - 2020
JO  - PloS one
DO  - 10.1371/journal.pone.0241448
UR  - https://doi.org/10.1371/journal.pone.0241448
ER  - 

APA

LA, W., A, F., R, P., J, D., J, K., J, M., K, F., M, K., & JV, C. (2020). In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.. PloS one. https://doi.org/10.1371/journal.pone.0241448

Source records